Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis.
Fox, Robert J.; Miller, David H.; Phillips, J. Theodore; Hutchinson, Michael; Havrdova, Eva; Kita, Mariko; Yang, Minhua; Raghupathi, Kartik; Novas, Mark; Sweetser, Marianne T.; Viglietta, Vissia; Dawson, Katherine T.; New England Journal of Medicine, 2012, vol. 367, issue 12, p 1087, ISSN 00284793. ISBN 00284793.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef